Vir Biotechnology Inc (NASDAQ: VIR) kicked off on Tuesday, up 12.88% from the previous trading day, before settling in for the closing price of $8.15. Over the past 52 weeks, VIR has traded in a range of $6.56-$13.09.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 421.39%. While this was happening, its average annual earnings per share was recorded 14.45%. With a float of $87.31 million, this company’s outstanding shares have now reached $136.71 million.
Considering the fact that the conglomerate employs 587 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 81.92%, operating margin of -658.31%, and the pretax margin is -685.83%.
Vir Biotechnology Inc (VIR) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Vir Biotechnology Inc is 36.61%, while institutional ownership is 49.46%. The most recent insider transaction that took place on Dec 02 ’24, was worth 625. Before that another transaction happened on Nov 06 ’24, when Company’s EVP and General Counsel sold 4,397 for $10.11, making the entire transaction worth $44,454. This insider now owns 56,973 shares in total.
Vir Biotechnology Inc (VIR) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 14.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.00% during the next five years compared to -34.12% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Take a look at Vir Biotechnology Inc’s (VIR) current performance indicators. Last quarter, stock had a quick ratio of 8.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.92, a number that is poised to hit -0.87 in the next quarter and is forecasted to reach -3.81 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Compared to the last year’s volume of 1.06 million, its volume of 1.68 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 82.31%. Additionally, its Average True Range was 0.60.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 59.46%, which indicates a significant decrease from 76.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 91.49% in the past 14 days, which was higher than the 62.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.93, while its 200-day Moving Average is $9.10. Nevertheless, the first resistance level for the watch stands at $9.82 in the near term. At $10.43, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.87. If the price goes on to break the first support level at $8.77, it is likely to go to the next support level at $8.33. Now, if the price goes above the second support level, the third support stands at $7.72.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
The company with the Market Capitalisation of 1.27 billion has total of 137,720K Shares Outstanding. Its annual sales at the moment are 86,180 K in contrast with the sum of -615,060 K annual income. Company’s last quarter sales were recorded 2,380 K and last quarter income was -213,720 K.
